Showing results (261-270 of 332) with videos related to

Sort By:
Pageof 34
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|June 2, 2020
Efficacy and safety of TNF antagonists in ocular sarcoidosis: data from the French registry STATAlicia Marquet, Catherine Chapelon-Abric, Delphine Maucort-Boulch, et al.
The Lancet. Neurology|February 21, 2026
Current evidence and knowledge gaps in family planning and pregnancy in myasthenia gravis, NMOSD, and MOGADDalia L Rotstein, Raed Alroughani, Georgina Arrambide, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 16, 2017
Natalizumab-PML survivors with subsequent MS treatment: Clinico-radiologic outcomeElisabeth Maillart, Jean-Sebastien Vidal, David Brassat, et al.
Plos One|January 4, 2017
Double-Blind Controlled Randomized Trial of Cyclophosphamide versus Methylprednisolone in Secondary Progressive Multiple SclerosisBruno Brochet, Mathilde S A Deloire, Paul Perez, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 9, 2024
Choroid plexus enlargement correlates with periventricular pathology but not with disease activity in radiologically isolated syndromeCassandre Landes-Château, Vito Ag Ricigliano, Lydiane Mondot, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 24, 2022
Neurofilament Light Chain Levels Are Predictive of Clinical Conversion in Radiologically Isolated SyndromeManon Rival, Eric Thouvenot, Lucile Du Trieu de Terdonck, et al.
Journal of Neurology|April 1, 2024
Big Multiple Sclerosis Data network: an international registry research networkAnna Glaser, Helmut Butzkueven, Anneke van der Walt, et al.
Annals of Clinical and Translational Neurology|September 10, 2021
A meta-analysis comparing first-line immunosuppressants in neuromyelitis opticaJonathan Giovannelli, Jonathan Ciron, Mikael Cohen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 24, 2022
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021Carmen Tur, Anne-Laure Dubessy, Susana Otero-Romero, et al.
CNS Drugs|May 30, 2018
MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled StudyAyman Tourbah, Olivier Gout, Alain Vighetto, et al.
Pageof 34